What about asthma in tuberculosis patients Source: Annual Congress 2011 - Management of tuberculosis Year: 2011
Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003
Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Comparison of serum IL-18 levels in tuberculosis with pneumonia, lung cancer and healthy controls Source: Eur Respir J 2003; 22: Suppl. 45, 340s Year: 2003
Cytokine and protein profile in BAL from patients with sarcoidosis and IPF Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Inhibiting effect of influenza vaccinations on serum eotaxin level in patients with allergic bronchial asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 134s Year: 2004
Expression of CCR3 on sputum macrophages in asthma, COPD and healthy subjects Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019
Serum levels of IL-10 and IL-12 i patients with pulmonary sarcoidosis Source: Annual Congress 2009 - Inflammation and airways Year: 2009
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017
The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009
Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007
Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
A level of an alpha-1-proteinihibitor in patients with chronic bronchitis and lung tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 339s Year: 2003
Incidence of allergic asthma in patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 232s Year: 2006
IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012